Australia has marked a significant public health milestone, recording no new diagnoses of cervical cancer in women under the age of 25 for the first time. This achievement fuels the nation’s ambitious goal of becoming the world’s first country to eliminate the disease entirely.
The remarkable decline in incidence among younger demographics is largely attributed to Australia’s pioneering national human papillomavirus (HPV) vaccination program, initiated in 2007. This comprehensive program, which targets adolescents, alongside robust cervical screening initiatives, has demonstrably altered the trajectory of the disease. Health experts point to the success of widespread vaccination, particularly with the Gardasil vaccine, in preventing the HPV infections that cause the vast majority of cervical cancers.
Building on this progress, Australia has set a target to reduce cervical cancer incidence to fewer than four cases per 100,000 women by 2035, a threshold widely recognized as a benchmark for elimination by global health organizations. Achieving this goal requires sustained effort across several fronts, including maintaining high HPV vaccination rates, ensuring equitable access to screening for all eligible populations, and improving follow-up and treatment for precancerous lesions.
While the zero cases in the under-25 age group is a powerful indicator of the program’s effectiveness, the journey to complete elimination still involves challenges. Efforts must continue to reach older women who may not have benefited from the vaccination program, address any remaining barriers to screening, and ensure that all communities, including remote and Indigenous populations, have equal access to preventative care. The nation’s progress serves as a compelling case study for other countries aiming to eradicate this preventable cancer.
